Table 1 Characteristics of COPD patients and controls
From: Association of mast cells with lung function in chronic obstructive pulmonary disease
Controls | COPD | |
|---|---|---|
N | 10 | 19 |
Male/female | 8/2 | 10/9 |
Current smoker (y/n/unknown) | 4/5/1* | 5/14/0 |
Age (median IQR) | 56 (47–70) | 62 (54–72) |
Packyears (median (range)) | 30 (25–50) * | 31 (27–40) |
ICS (y/n/unknown) | 0/9/1* | 8/11/0 |
OCS (y/n/unknown) | 0/9/1* | 7/12/0 |
ICS and/or OCS (y/n/unknown) | 0/9/1* | 13/6/0 |
B2 agonist (y/n/unknown) | 0/9/1* | 10/9/0 |
Anticholinergics (y/n/unknown) | 0/9/1* | 10/9/0 |
COPD Severity Stage (GOLD 1/2/3/4) | - | 3/8/1/7 |
FEV1 (% predicted) | 103 (92–107)** | 56 (23–75) |
FEV1/IVC (%) | 72 (72–75)** | 50 (30–59) |